HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Transient Hypogonadism Is Associated With Heart Rate-Corrected QT Prolongation and Torsades de Pointes Risk During Active Systemic Inflammation in Men.

Abstract
Background Systemic inflammation and male hypogonadism are 2 increasingly recognized "nonconventional" risk factors for long-QT syndrome and torsades de pointes (TdP). Specifically, inflammatory cytokines prolong, while testosterone shortens the heart rate-corrected QT interval (QTc) via direct electrophysiological effects on cardiomyocytes. Moreover, several studies demonstrated important interplays between inflammation and reduced gonad function in men. We hypothesized that, during inflammatory activation in men, testosterone levels decrease and that this enhances TdP risk by contributing to the overall prolonging effect of inflammation on QTc. Methods and Results We investigated (1) the levels of sex hormones and their relationship with inflammatory markers and QTc in male patients with different types of inflammatory diseases, during active phase and recovery; and (2) the association between inflammatory markers and sex hormones in a cohort of male patients who developed extreme QTc prolongation and TdP, consecutively collected over 10 years. In men with active inflammatory diseases, testosterone levels were significantly reduced, but promptly normalized in association with the decrease in C-reactive protein and interleukin-6 levels. Reduction of testosterone levels, which also inversely correlated with 17-β estradiol over time, significantly contributed to inflammation-induced QTc prolongation. In men with TdP, both active systemic inflammation and hypogonadism were frequently present, with significant correlations between C-reactive protein, testosterone, and 17-β estradiol levels; in these patients, increased C-reactive protein and reduced testosterone were associated with a worse short-term outcome of the arrhythmia. Conclusions During systemic inflammatory activation, interleukin-6 elevation is associated with reduced testosterone levels in males, possibly deriving from an enhanced androgen-to-estrogen conversion. While transient, inflammatory hypotestosteronemia is significantly associated with an increased long-QT syndrome/TdP risk in men.
AuthorsPietro Enea Lazzerini, Silvia Cantara, Iacopo Bertolozzi, Riccardo Accioli, Viola Salvini, Alessandra Cartocci, Antonio D'Errico, Fausta Sestini, Stefania Bisogno, Gabriele Cevenini, Matteo Capecchi, Franco Laghi-Pasini, Maria Grazia Castagna, Maurizio Acampa, Mohamed Boutjdir, Pier Leopoldo Capecchi
JournalJournal of the American Heart Association (J Am Heart Assoc) Vol. 11 Issue 1 Pg. e023371 (01 04 2022) ISSN: 2047-9980 [Electronic] England
PMID34935398 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • DNA-Binding Proteins
  • Gonadal Steroid Hormones
  • Interleukin-6
  • Testosterone
  • Estradiol
  • C-Reactive Protein
Topics
  • C-Reactive Protein
  • DNA-Binding Proteins
  • Electrocardiography
  • Estradiol
  • Gonadal Steroid Hormones
  • Heart Rate
  • Humans
  • Hypogonadism (complications, diagnosis)
  • Inflammation (complications)
  • Interleukin-6
  • Long QT Syndrome (chemically induced)
  • Male
  • Risk Factors
  • Testosterone
  • Torsades de Pointes (chemically induced, diagnosis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: